[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Wagner Zago Biography and Net Worth

Insider of Prothena

Dr. Zago has served as our Chief Scientific Officer since 2017. He joined Prothena in 2012 when the company was founded, first as Head of Pharmacology and Neuropathology and more recently as Vice President, Head of Research. Between 2006 and 2012, Dr. Zago was Principal Scientist at Elan Pharmaceuticals, Inc., performing research aimed at developing new therapeutics for CNS disorders, including beta amyloid-targeted therapies and supportive research for the development of natalizumab, which was commercialized by Biogen for relapsing multiple sclerosis. While in this position, between 2009 and 2013, he also served as a Scientist at Janssen Alzheimer Immunotherapy, where he made significant discoveries about vascular changes associated with anti-beta amyloid immunotherapy. Dr. Zago earned his BS in Biomedicine from the Universidade Federal de Sao Paulo (Escola Paulista de Medicina), Brazil, and his M.S. and Ph.D. in Pharmacology at the Universidade de Sao Paulo, Brazil, and was a Post-Doctoral Researcher at the University of California – San Diego and the Burnham Institute.

What is Wagner M. Zago's net worth?: The estimated net worth of Wagner M. Zago is at least $219,000.00 as of June 22nd, 2021. Dr. Zago owns 15,000 shares of Prothena stock worth more than $219,000 as of November 24th. This net worth evaluation does not reflect any other assets that Dr. Zago may own. Additionally, Dr. Zago receives a salary of $478,790.00 as Insider at Prothena. Learn More about Wagner M. Zago's net worth.
How old is Wagner M. Zago?: Dr. Zago is currently 51 years old. There are 6 older executives and no younger executives at Prothena. The oldest executive at Prothena is Ms. Carol D. Karp, Chief Regulatory Officer, who is 71 years old. Learn More on Wagner M. Zago's age.
What is Wagner M. Zago's salary?: As the Insider of Prothena Co. plc, Dr. Zago earns $478,790.00 per year. There are 5 executives that earn more than Dr. Zago. The highest earning executive at Prothena is Dr. Gene G. Kinney Ph.D., President, CEO & Director, who commands a salary of $1,000,000.00 per year. Learn More on Wagner M. Zago's salary.
How do I contact Wagner M. Zago?: The corporate mailing address for Dr. Zago and other Prothena executives is 77 SIR JOHN ROGERSON`S QUAY BLOCK C GRAND CANAL DOCKLANDS, DUBLIN 2 L2, D02 T804. Prothena can also be reached via phone at (531) 236-2500 and via email at [email protected]. Learn More on Wagner M. Zago's contact information.
Has Wagner M. Zago been buying or selling shares of Prothena?: Wagner M. Zago has not been actively trading shares of Prothena over the course of the past ninety days. Most recently, Wagner M. Zago sold 4,000 shares of the business's stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $67.05, for a transaction totalling $268,200.00. Learn More on Wagner M. Zago's trading history.
Who are Prothena's active insiders?: Prothena's insider roster includes Christopher Henney (Director), Carol Karp (Insider), Gene Kinney (Pres), Michael Malecek (Insider), Tran Nguyen (CFO & Chief Strategy Officer ), Dennis Selkoe (Director), Karin Walker (CAO), and Wagner Zago (Insider). Learn More on Prothena's active insiders.
Are insiders buying or selling shares of Prothena?: During the last twelve months, insiders at the biotechnology company sold shares 3 times. They sold a total of 15,000 shares worth more than $525,950.00. The most recent insider tranaction occured on January, 24th when CAO Karin L. Walker sold 5,000 shares worth more than $170,000.00. Insiders at Prothena own 28.2% of the company. Learn More about insider trades at Prothena.
Information on this page was last updated on 1/24/2024.

Wagner M. Zago Insider Trading History at Prothena

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/2/2023	Sell	4,000	$67.05	$268,200.00
6/7/2023	Sell	19,000	$71.06	$1,350,140.00
6/22/2021	Sell	115,250	$46.15	$5,318,787.50	15,000
2/18/2021	Sell	7,540	$25.50	$192,270.00	7,540

Wagner M. Zago Buying and Selling Activity at Prothena

Prothena Company Overview

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. The company is involved in developing birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, for the treatment of Parkinson's disease and other related synucleinopathies which is in Phase IIb clinical trial; NNC6019 that is in Phase lI clinical trial for the treatment of ATTR amyloidosis; and BMS-986446 and PRX012, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX123, a dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease; and PRX019 for the treatment of neurogenerative diseases, as well as TDP-43 for the treatment of amyotrophic lateral sclerosis. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and a collaboration agreement with Bristol-Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. The company was incorporated in 2012 and is based in Dublin, Ireland.

Today's Range

Now: $14.60

$14.03

$15.33

50 Day Range

MA: $17.51

$13.51

$22.02

2 Week Range

Now: $14.60

$13.22

$41.54

Volume

468,844 shs

Average Volume

509,059 shs

Market Capitalization

$785.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

Wagner Zago Biography and Net Worth

What is Wagner M. Zago's net worth?

How old is Wagner M. Zago?

What is Wagner M. Zago's salary?

How do I contact Wagner M. Zago?

Has Wagner M. Zago been buying or selling shares of Prothena?

Who are Prothena's active insiders?

Are insiders buying or selling shares of Prothena?